0001225208-22-000110.txt : 20220103
0001225208-22-000110.hdr.sgml : 20220103
20220103164956
ACCESSION NUMBER: 0001225208-22-000110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220101
FILED AS OF DATE: 20220103
DATE AS OF CHANGE: 20220103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fitzgerald Joseph Michael
CENTRAL INDEX KEY: 0001484186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 22502737
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2022-01-01
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001484186
Fitzgerald Joseph Michael
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP & Pres, Cardiology
Common Stock
2022-01-01
4
M
0
14035.0000
0.0000
A
217631.0000
D
Common Stock
2022-01-01
4
F
0
7099.0000
42.4800
D
210532.0000
D
Common Stock
68251.0000
I
By 401(k)
Common Stock
6038.0000
I
By Children
Performance Share Units
2022-01-01
4
M
0
14035.0000
0.0000
D
2021-12-31
2021-12-31
Common Stock
14035.0000
0.0000
D
On February 21, 2019, the reporting person was awarded a target number of performance share units under the Company's 2019 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2019 adjusted free cash flow measured against its 2019 financial plan over the one-year performance period ending December 31, 2019 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 24, 2020, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2021.
Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.
Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
/s/ Vance R. Brown, Attorney-in-fact
2022-01-02